VitaHealth Analysis Comprehensive Cancer – Female
What’s it used for?
The test is used to provide information regarding indicators for common cancers that affect women, including ovarian, colon, rectal, stomach, pancreas, breast and liver cancer.
The presence of the carcinoembryonic antigen (CEA) in the blood may indicate certain kinds of cancers, typically colon and rectal, but sometimes pancreas, breast or lung. Similarly, the presence of alpha-fetoprotein (AFP) in women who are not pregnant may point toward cancer of the stomach, ovaries, pancreas or liver. High levels may indicate Hodgkins disease, brain tumors, renal cell cancer or lymphoma. Cancer antigen (CA) 125, CA 27-29, CA 15-3 and CA 19-9 are tumor markers for ovarian cancer, breast cancer and pancreatic cancer respectively.